- Faced with numerous questions from EU lawmakers on Monday (10 October), pharmaceutical giant Pfizer remained vague about the opacity of its vaccine purchase contracts and the text messages exchanged with European Commission President Ursula von der Leyen.
- The European Parliament’s special committee on COVID (COVI committee) heard several pharmaceutical companies, including Pfizer, on Monday about their roles in the management of the pandemic.
- Small had to deal with controversy, starting with the opacity of the contracts for the purchase of COVID-19 vaccines.
Pfizer remains discreet about COVID vaccine purchase contracts
